Siu-Wai Choi, Dileep Sharma, Poornima Ramamurthy, Peter Thomson
{"title":"Oral cancer: licensed to kill?","authors":"Siu-Wai Choi, Dileep Sharma, Poornima Ramamurthy, Peter Thomson","doi":"10.1308/rcsfdj.2023.29","DOIUrl":null,"url":null,"abstract":"Oral squamous cell carcinoma (OSCC) is a lethal disease of global significance. Having previously demonstrated a rising incidence and worsening mortality in a retrospective analysis of 9,887 OSCC patients diagnosed in Queensland, Australia, the authors of this paper re-analysed patient cohort data to determine the cause of death. Overall, 5,859 patients died: 3,585 (61.2%) from a cancer related episode in the head and neck, 796 (13.6%) from cancer outside the head and neck region, and 1,478 (25.2%) from a non-cancer related cause. Improved understanding of the cause of death offers important opportunities to enhance contemporary care provision, including more accurate prediction of mortality outcomes, recognition of patients whose pre-existent comorbidities limit the efficacy of intensified treatment modalities, and the delivery of better post-treatment screening and tertiary preventive strategies.","PeriodicalId":475077,"journal":{"name":"Faculty Dental Journal","volume":"18 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Faculty Dental Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1308/rcsfdj.2023.29","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Oral squamous cell carcinoma (OSCC) is a lethal disease of global significance. Having previously demonstrated a rising incidence and worsening mortality in a retrospective analysis of 9,887 OSCC patients diagnosed in Queensland, Australia, the authors of this paper re-analysed patient cohort data to determine the cause of death. Overall, 5,859 patients died: 3,585 (61.2%) from a cancer related episode in the head and neck, 796 (13.6%) from cancer outside the head and neck region, and 1,478 (25.2%) from a non-cancer related cause. Improved understanding of the cause of death offers important opportunities to enhance contemporary care provision, including more accurate prediction of mortality outcomes, recognition of patients whose pre-existent comorbidities limit the efficacy of intensified treatment modalities, and the delivery of better post-treatment screening and tertiary preventive strategies.